Calamos Advisors »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Calamos Advisors

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $24M 23M 1.04

More positions owned by Calamos Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Western Digital Corp Note 3.000%11/1 (Principal)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1